SurModics, Inc.
SRDX
$30.11
-$0.65-2.11%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -2.06% | 18.80% | -42.19% | 17.50% | 22.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -2.06% | 18.80% | -42.19% | 17.50% | 22.54% |
| Cost of Revenue | -6.30% | 33.07% | 0.33% | -7.14% | 231.63% |
| Gross Profit | 3.60% | -7.99% | -64.67% | 71.37% | -33.46% |
| SG&A Expenses | 2.69% | -15.05% | 29.15% | 0.97% | -5.28% |
| Depreciation & Amortization | -0.80% | 0.80% | -1.02% | 1.04% | -4.71% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -2.50% | -0.92% | 11.92% | -3.68% | -4.00% |
| Operating Income | 43.79% | 226.00% | -126.09% | 112.44% | 95.54% |
| Income Before Tax | -306.63% | 59.23% | -128.14% | 102.25% | 90.96% |
| Income Tax Expenses | 1,040.32% | 124.38% | -86.90% | -122.01% | 137.58% |
| Earnings from Continuing Operations | -364.50% | -151.52% | -202.83% | 103.19% | 89.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -364.50% | -151.52% | -202.83% | 103.19% | 89.98% |
| EBIT | 43.79% | 226.00% | -126.09% | 112.44% | 95.54% |
| EBITDA | -5.42% | 1,883.62% | -114.27% | 185.93% | 139.40% |
| EPS Basic | -360.68% | -151.07% | -201.97% | 103.17% | 90.07% |
| Normalized Basic EPS | 11.84% | 191.05% | -129.08% | 102.70% | 91.03% |
| EPS Diluted | -333.33% | -152.55% | -202.52% | 103.17% | 89.30% |
| Normalized Diluted EPS | 11.84% | 191.64% | -129.13% | 102.70% | 91.03% |
| Average Basic Shares Outstanding | 0.91% | 0.90% | 0.85% | 0.87% | 0.85% |
| Average Diluted Shares Outstanding | 0.91% | 0.26% | 0.70% | 1.08% | 0.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
